Pseudomonas species causing urinary tract infection and its antibiogram at a tertiary care hospital

K. L. Shobha, L. Ramachandra, Amita Shobha Rao, K. M. Anand, S. Gowrish Rao

Research output: Contribution to journalArticle

Abstract

Objectives: Pseudomonas species cause urinary tract infection (UTI). This study was conducted to isolate Pseudomonas species causing significant bacteriuria and to analyze its antibiogram at a tertiary care hospital. Methods: About 107 urine samples received in the laboratory from August 2015 to July 2016 having significant bacteriuria with Pseudomonas species were tested for antimicrobial activity. Samples were from both inpatients and patients attending as outpatients to a tertiary care hospital with different age groups and gender. Midstream urine samples were inoculated using a standard calibrated loop into blood agar and MacConkey agar following semi quantitative technique using Kass concept. MALD (Biomerio, ElToile, France) was used for speciation, and Vitex automated system (Biomerio, ElToile, France) was used for antibacterial sensitivity testing. Results: About 107 urine samples contained Pseudomonas species by MALDI obtained from 69 male (64.48%) and 38 (35.51%) female patients. Inpatients were 90 (84.11%) and 17 (15.88%) outpatient department (OPD) patients. Isolation of Pseudomonas aeruginosa was from 90 samples (84.11%) and Pseudomonas putida in 17 (15.88%). Significant bacteriuria was more in the age group of >60 years in both genders. Susceptibility to gentamicin was 52 (48.59%), ceftazidime 56 (52.33%), and imipenem was 58 (54.20%). Organism was multidrug resistant in 49 (45.79%) samples. Conclusion: P. aeruginosa remains the most common uropathogen among Pseudomonas species. Drug of choice for inpatients suffering from UTI by Pseudomonas species can be gentamicin and for patients attending OPD can be ceftazidime. Imipenem can be the reserve drug. Periodic antibiotic review is required for proper treatment of UTI.

Original languageEnglish
Pages (from-to)50-51
Number of pages2
JournalAsian Journal of Pharmaceutical and Clinical Research
Volume10
Issue number11
DOIs
Publication statusPublished - 01-11-2017

Fingerprint

Microbial Sensitivity Tests
Tertiary Healthcare
Pseudomonas
Tertiary Care Centers
Urinary Tract Infections
Bacteriuria
Inpatients
Outpatients
Ceftazidime
Imipenem
Urine
Gentamicins
Pseudomonas aeruginosa
Agar
France
Age Groups
Vitex
Pseudomonas putida
Matrix-Assisted Laser Desorption-Ionization Mass Spectrometry
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)

Cite this

Shobha, K. L. ; Ramachandra, L. ; Rao, Amita Shobha ; Anand, K. M. ; Gowrish Rao, S. / Pseudomonas species causing urinary tract infection and its antibiogram at a tertiary care hospital. In: Asian Journal of Pharmaceutical and Clinical Research. 2017 ; Vol. 10, No. 11. pp. 50-51.
@article{4ab82751215a490b9226fb6b82b1aa2c,
title = "Pseudomonas species causing urinary tract infection and its antibiogram at a tertiary care hospital",
abstract = "Objectives: Pseudomonas species cause urinary tract infection (UTI). This study was conducted to isolate Pseudomonas species causing significant bacteriuria and to analyze its antibiogram at a tertiary care hospital. Methods: About 107 urine samples received in the laboratory from August 2015 to July 2016 having significant bacteriuria with Pseudomonas species were tested for antimicrobial activity. Samples were from both inpatients and patients attending as outpatients to a tertiary care hospital with different age groups and gender. Midstream urine samples were inoculated using a standard calibrated loop into blood agar and MacConkey agar following semi quantitative technique using Kass concept. MALD (Biomerio, ElToile, France) was used for speciation, and Vitex automated system (Biomerio, ElToile, France) was used for antibacterial sensitivity testing. Results: About 107 urine samples contained Pseudomonas species by MALDI obtained from 69 male (64.48{\%}) and 38 (35.51{\%}) female patients. Inpatients were 90 (84.11{\%}) and 17 (15.88{\%}) outpatient department (OPD) patients. Isolation of Pseudomonas aeruginosa was from 90 samples (84.11{\%}) and Pseudomonas putida in 17 (15.88{\%}). Significant bacteriuria was more in the age group of >60 years in both genders. Susceptibility to gentamicin was 52 (48.59{\%}), ceftazidime 56 (52.33{\%}), and imipenem was 58 (54.20{\%}). Organism was multidrug resistant in 49 (45.79{\%}) samples. Conclusion: P. aeruginosa remains the most common uropathogen among Pseudomonas species. Drug of choice for inpatients suffering from UTI by Pseudomonas species can be gentamicin and for patients attending OPD can be ceftazidime. Imipenem can be the reserve drug. Periodic antibiotic review is required for proper treatment of UTI.",
author = "Shobha, {K. L.} and L. Ramachandra and Rao, {Amita Shobha} and Anand, {K. M.} and {Gowrish Rao}, S.",
year = "2017",
month = "11",
day = "1",
doi = "10.22159/ajpcr.2017.v10i11.20002",
language = "English",
volume = "10",
pages = "50--51",
journal = "Asian Journal of Pharmaceutical and Clinical Research",
issn = "0974-2441",
publisher = "Innovare Academics Sciences Pvt. Ltd",
number = "11",

}

Pseudomonas species causing urinary tract infection and its antibiogram at a tertiary care hospital. / Shobha, K. L.; Ramachandra, L.; Rao, Amita Shobha; Anand, K. M.; Gowrish Rao, S.

In: Asian Journal of Pharmaceutical and Clinical Research, Vol. 10, No. 11, 01.11.2017, p. 50-51.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Pseudomonas species causing urinary tract infection and its antibiogram at a tertiary care hospital

AU - Shobha, K. L.

AU - Ramachandra, L.

AU - Rao, Amita Shobha

AU - Anand, K. M.

AU - Gowrish Rao, S.

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Objectives: Pseudomonas species cause urinary tract infection (UTI). This study was conducted to isolate Pseudomonas species causing significant bacteriuria and to analyze its antibiogram at a tertiary care hospital. Methods: About 107 urine samples received in the laboratory from August 2015 to July 2016 having significant bacteriuria with Pseudomonas species were tested for antimicrobial activity. Samples were from both inpatients and patients attending as outpatients to a tertiary care hospital with different age groups and gender. Midstream urine samples were inoculated using a standard calibrated loop into blood agar and MacConkey agar following semi quantitative technique using Kass concept. MALD (Biomerio, ElToile, France) was used for speciation, and Vitex automated system (Biomerio, ElToile, France) was used for antibacterial sensitivity testing. Results: About 107 urine samples contained Pseudomonas species by MALDI obtained from 69 male (64.48%) and 38 (35.51%) female patients. Inpatients were 90 (84.11%) and 17 (15.88%) outpatient department (OPD) patients. Isolation of Pseudomonas aeruginosa was from 90 samples (84.11%) and Pseudomonas putida in 17 (15.88%). Significant bacteriuria was more in the age group of >60 years in both genders. Susceptibility to gentamicin was 52 (48.59%), ceftazidime 56 (52.33%), and imipenem was 58 (54.20%). Organism was multidrug resistant in 49 (45.79%) samples. Conclusion: P. aeruginosa remains the most common uropathogen among Pseudomonas species. Drug of choice for inpatients suffering from UTI by Pseudomonas species can be gentamicin and for patients attending OPD can be ceftazidime. Imipenem can be the reserve drug. Periodic antibiotic review is required for proper treatment of UTI.

AB - Objectives: Pseudomonas species cause urinary tract infection (UTI). This study was conducted to isolate Pseudomonas species causing significant bacteriuria and to analyze its antibiogram at a tertiary care hospital. Methods: About 107 urine samples received in the laboratory from August 2015 to July 2016 having significant bacteriuria with Pseudomonas species were tested for antimicrobial activity. Samples were from both inpatients and patients attending as outpatients to a tertiary care hospital with different age groups and gender. Midstream urine samples were inoculated using a standard calibrated loop into blood agar and MacConkey agar following semi quantitative technique using Kass concept. MALD (Biomerio, ElToile, France) was used for speciation, and Vitex automated system (Biomerio, ElToile, France) was used for antibacterial sensitivity testing. Results: About 107 urine samples contained Pseudomonas species by MALDI obtained from 69 male (64.48%) and 38 (35.51%) female patients. Inpatients were 90 (84.11%) and 17 (15.88%) outpatient department (OPD) patients. Isolation of Pseudomonas aeruginosa was from 90 samples (84.11%) and Pseudomonas putida in 17 (15.88%). Significant bacteriuria was more in the age group of >60 years in both genders. Susceptibility to gentamicin was 52 (48.59%), ceftazidime 56 (52.33%), and imipenem was 58 (54.20%). Organism was multidrug resistant in 49 (45.79%) samples. Conclusion: P. aeruginosa remains the most common uropathogen among Pseudomonas species. Drug of choice for inpatients suffering from UTI by Pseudomonas species can be gentamicin and for patients attending OPD can be ceftazidime. Imipenem can be the reserve drug. Periodic antibiotic review is required for proper treatment of UTI.

UR - http://www.scopus.com/inward/record.url?scp=85034098977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034098977&partnerID=8YFLogxK

U2 - 10.22159/ajpcr.2017.v10i11.20002

DO - 10.22159/ajpcr.2017.v10i11.20002

M3 - Article

VL - 10

SP - 50

EP - 51

JO - Asian Journal of Pharmaceutical and Clinical Research

JF - Asian Journal of Pharmaceutical and Clinical Research

SN - 0974-2441

IS - 11

ER -